Dose-related neurocognitive effects of marijuana use.

PubWeight™: 3.25‹?› | Rank: Top 1%

🔗 View Article (PMID 12427880)

Published in Neurology on November 12, 2002

Authors

K I Bolla1, K Brown, D Eldreth, K Tate, J L Cadet

Author Affiliations

1: Department of Neurology, Johns Hopkins University School of Medicine, Hopkins Bayview Research Campus, Baltimore, MD 21224, USA. kbolla@jhmi.edu

Articles citing this

(truncated to the top 100)

Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67

Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl) (2007) 2.37

Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology (Berl) (2012) 2.36

The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int (2012) 2.31

An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06

Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc (2007) 2.05

Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) (2006) 1.92

The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev (2008) 1.78

Marijuana use and motor vehicle crashes. Epidemiol Rev (2011) 1.74

Functional consequences of marijuana use in adolescents. Pharmacol Biochem Behav (2009) 1.71

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One (2013) 1.59

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2004) 1.56

The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend (2007) 1.54

Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54

Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav (2010) 1.51

Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 1.50

Sleep disturbance in heavy marijuana users. Sleep (2008) 1.49

Age of onset of marijuana use and executive function. Psychol Addict Behav (2011) 1.46

Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry (2005) 1.43

Parental transmission of risk for cannabis use disorders to offspring. Addiction (2015) 1.40

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend (2009) 1.40

Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. Neuroimage (2009) 1.39

Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl) (2012) 1.37

Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37

Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res (2011) 1.36

Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology (Berl) (2011) 1.33

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32

Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem (2013) 1.29

Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem (2007) 1.24

Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol (2011) 1.23

Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res (2010) 1.22

Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction (2009) 1.21

Working memory and decision-making biases in young adults with a family history of alcoholism: studies from the Oklahoma family health patterns project. Alcohol Clin Exp Res (2006) 1.19

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18

Substance abuse by children and young people. Arch Dis Child (2004) 1.16

Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsychol (2012) 1.15

Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14

Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci (2014) 1.14

Neuropsychological deficits associated with cannabis use in young adults. Drug Alcohol Depend (2011) 1.12

Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol (2006) 1.10

The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs (2010) 1.10

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol (2009) 1.09

Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology (Berl) (2010) 1.05

Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci (2015) 1.03

Age of onset of marijuana use impacts inhibitory processing. Neurosci Lett (2012) 1.02

The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl) (2009) 0.99

Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol Addict Behav (2007) 0.99

Working memory and impulsivity predict marijuana-related problems among frequent users. Drug Alcohol Depend (2013) 0.99

Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug Alcohol Depend (2008) 0.97

Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. J Neurochem (2009) 0.97

Trends Among U.S. High School Seniors in Recent Marijuana Use and Associations With Other Substances: 1976-2013. J Adolesc Health (2015) 0.96

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. Philos Trans R Soc Lond B Biol Sci (2012) 0.95

The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users. J Int Neuropsychol Soc (2012) 0.94

Neurocognition in college-aged daily marijuana users. J Clin Exp Neuropsychol (2014) 0.93

Cannabis, motivation, and life satisfaction in an internet sample. Subst Abuse Treat Prev Policy (2006) 0.93

Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol (2008) 0.93

Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. Addict Behav (2012) 0.93

Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects. J Addict Med (2013) 0.93

Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des (2014) 0.92

Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med (2010) 0.92

Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology (Berl) (2010) 0.92

Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage (2011) 0.92

Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol (2009) 0.92

AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder. Neuropsychopharmacology (2011) 0.92

Preliminary evidence for a sex-specific relationship between amount of cannabis use and neurocognitive performance in young adult cannabis users. J Int Neuropsychol Soc (2013) 0.91

Effects of chronic, heavy cannabis use on executive functions. J Addict Med (2011) 0.91

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology (Berl) (2012) 0.91

Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophr Bull (2015) 0.91

Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol (2010) 0.90

Building smart cannabis policy from the science up. Int J Drug Policy (2017) 0.90

Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci (2011) 0.90

Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res (2011) 0.89

Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology (2014) 0.89

Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. J Stud Alcohol Drugs (2010) 0.89

COMT val158met and 5-HTTLPR genetic polymorphisms moderate executive control in cannabis users. Neuropsychopharmacology (2013) 0.89

Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. Biol Psychiatry (2015) 0.89

Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berl) (2008) 0.89

Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies. Proc Natl Acad Sci U S A (2016) 0.89

Auditory mismatch negativity deficits in long-term heavy cannabis users. Eur Arch Psychiatry Clin Neurosci (2010) 0.88

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Transl Psychiatry (2014) 0.87

Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment. Drug Alcohol Depend (2014) 0.87

Unique functional abnormalities in youth with combined marijuana use and depression: an FMRI study. Front Psychiatry (2014) 0.87

AAV-Mediated Overexpression of the CB1 Receptor in the mPFC of Adult Rats Alters Cognitive Flexibility, Social Behavior, and Emotional Reactivity. Front Behav Neurosci (2011) 0.86

Cannabis in sport: anti-doping perspective. Sports Med (2011) 0.86

Functional brain imaging of development-related risk and vulnerability for substance use in adolescents. J Addict Med (2009) 0.86

Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. Cold Spring Harb Perspect Med (2013) 0.86

The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci (2012) 0.85

Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence. J Clin Exp Neuropsychol (2011) 0.85

Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep (2014) 0.85

How high: quantity as a predictor of cannabis-related problems. Harm Reduct J (2008) 0.85

The academic consequences of marijuana use during college. Psychol Addict Behav (2015) 0.84

Medical marijuana in the workplace: challenges and management options for occupational physicians. J Occup Environ Med (2015) 0.84

Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) (2007) 0.83

Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students. Drug Alcohol Depend (2013) 0.83

Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder. Psychopharmacology (Berl) (2014) 0.83

The effect of cannabis use on memory function: an update. Subst Abuse Rehabil (2013) 0.83

The primacy of cognition in the manifestations of substance use disorders. Front Neurol (2013) 0.82

The impact of initiation: Early onset marijuana smokers demonstrate altered Stroop performance and brain activation. Dev Cogn Neurosci (2015) 0.82

Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment. AIDS Behav (2016) 0.82

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. J Psychopharmacol (2009) 0.82

Articles by these authors

(truncated to the top 100)

Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature (1999) 23.62

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol (1994) 8.98

Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (1986) 6.14

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45

Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13

Nucleotide sequence of the leader region of the phenylalanine operon of Escherichia coli. Proc Natl Acad Sci U S A (1978) 4.01

Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J (1988) 3.89

Cbl-b regulates the CD28 dependence of T-cell activation. Nature (2000) 3.89

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63

Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther (2011) 3.63

Increase in asthma: a more toxic environment or a more susceptible population? Thorax (1994) 3.52

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell (1993) 3.35

Racism and the physical and mental health status of African Americans: a thirteen year national panel study. Ethn Dis (1996) 3.34

Use of component analyses to identify active variables in treatment packages for children with feeding disorders. J Appl Behav Anal (1995) 3.24

Inappropriate reattendances in out-patient departments. J Public Health Med (1992) 3.14

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet (2001) 3.12

Mitomycin C-induced expression of trpA of Salmonella typhimurium inserted into the plasmid ColE1. J Bacteriol (1977) 3.06

Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol (1995) 3.05

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93

Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr (1998) 2.87

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res (2001) 2.51

QALYs for resource allocation: probably not and certainly not now. Aust J Public Health (1993) 2.46

Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (1996) 2.40

Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell (1990) 2.34

Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A (1998) 2.32

Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport (2001) 2.19

The effects of presession exposure to attention on the results of assessments of attention as a reinforcer. J Appl Behav Anal (2000) 2.12

Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci (2000) 2.10

Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03

The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration. Br J Clin Pharmacol (1986) 2.03

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03

Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill (2009) 2.01

Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc Natl Acad Sci U S A (1995) 1.95

Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet (1998) 1.88

Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol (1994) 1.85

Nerves on magnetic resonance imaging. J Natl Med Assoc (1989) 1.85

Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace. Health Psychol (1988) 1.83

Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development (1998) 1.81

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci (1992) 1.79

Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha. J Biol Chem (1996) 1.78

Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1999) 1.77

v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell (1986) 1.76

Oncogene activation in chemical carcinogenesis. Adv Cancer Res (1988) 1.72

Radioimmunoassay of sodium cromoglycate in human plasma. Ann Clin Biochem (1983) 1.72

Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res (2001) 1.71

Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology (2010) 1.69

The impact of nursing home patients on general practitioners' workload. Br J Gen Pract (2000) 1.64

Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64

Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res (1999) 1.63

Physical Aspects of Fruit Growth : THEORETICAL ANALYSIS OF DISTRIBUTION OF SURFACE GROWTH FORCES IN FRUIT IN RELATION TO CRACKING AND SPLITTING. Plant Physiol (1981) 1.62

Complete nucleotide sequence of recD, the structural gene for the alpha subunit of Exonuclease V of Escherichia coli. Nucleic Acids Res (1986) 1.62

The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J (1993) 1.61

Pitfalls in the diagnosis of thoracic aortic dissection at CT angiography. Radiographics (2000) 1.59

Sex-related differences in a gambling task and its neurological correlates. Cereb Cortex (2004) 1.58

Bronchial reactivity and dietary antioxidants. Thorax (1997) 1.56

Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther (2007) 1.56

The facilitation of discrimination performance by physostigmine sulphate. Psychopharmacologia (1972) 1.55

Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A (1998) 1.54

Mechanism of Cdc42-induced actin polymerization in neutrophil extracts. J Cell Biol (1998) 1.51

Reduced kidney function in living kidney donors. Kidney Int (2007) 1.49

Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49

Relative rates of AIDS among racial/ethnic groups by exposure categories. J Natl Med Assoc (1999) 1.49

The possible site of action of sodium cromoglycate assessed by exercise challenge. Clin Sci Mol Med (1974) 1.49

Knowledge and beliefs regarding the consequences of cigarette smoking and their relationships to smoking status in a biracial sample. Health Psychol (1988) 1.48

Airway foreign bodies (FB): a 10-year review. Int J Pediatr Otorhinolaryngol (2000) 1.48

c-kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol (1988) 1.47

Complete nucleotide sequence of the Escherichia coli recB gene. Nucleic Acids Res (1986) 1.47

Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46

Structure-function of recombinant Na/H exchanger regulatory factor (NHE-RF). J Clin Invest (1998) 1.44

Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol (1999) 1.43

Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B. Mol Cell Biol (1994) 1.43

Creation of a gilded trap by the high economic value of the Maine lobster fishery. Conserv Biol (2011) 1.41

Low serum iron levels and neuroleptic malignant syndrome. Am J Psychiatry (1991) 1.40

Paediatric neurology and paediatric neurologists. Dev Med Child Neurol (1994) 1.38

Compensating the transplant professional: time for a model change. Am J Transplant (2015) 1.38

The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38

Crystallization and preliminary X-ray analysis of the 9 kDa protein of the mouse signal recognition particle and the selenomethionyl-SRP9. FEBS Lett (1996) 1.38

Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer. Acta Oncol (2006) 1.37

Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology (2000) 1.34

Antioxidant intake and adult-onset wheeze: a case-control study. Aberdeen WHEASE Study Group. Eur Respir J (1999) 1.34

The effect of irreversible image compression on diagnostic accuracy in thoracic imaging. Invest Radiol (1993) 1.33

Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J Biol Chem (1997) 1.32

Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol (1999) 1.32

Identifying reefs of hope and hopeful actions: contextualizing environmental, ecological, and social parameters to respond effectively to climate change. Conserv Biol (2009) 1.31

Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem (2000) 1.31

Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol (1993) 1.30

Complete nucleotide sequence of the Escherichia coli ptr gene encoding protease III. Nucleic Acids Res (1986) 1.30

Complete nucleotide sequence of the Escherichia coli recC gene and of the thyA-recC intergenic region. Nucleic Acids Res (1986) 1.28

The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem (1985) 1.28

Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol (2011) 1.27

Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess (2010) 1.26

A molecular and biochemical analysis of the structure of the cyanogenic beta-glucosidase (linamarase) from cassava (Manihot esculenta Cranz). Arch Biochem Biophys (1992) 1.25

Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med (2006) 1.22

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med (2013) 1.21

Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores. Osteoporos Int (2008) 1.20

Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem (2001) 1.20